<DOC>
	<DOCNO>NCT00821392</DOCNO>
	<brief_summary>This study design evalute efficacy safety Febuxostat oral administration patientd gout Korea</brief_summary>
	<brief_title>Phase III Trial Febuxostat Korea Gout Patients</brief_title>
	<detailed_description>This multi-center , randomize , double-blind , allopurinol placebo control , parallel , 5 arm , dose response , bridge study 4 week duration . If subject pass screen evaluation submitting sign informed consent , randomly assign one five treatment regimen ; febuxostat 40mg , 80mg , 120mg , placebo allopurinol 300mg . Colchicine 0.6mg QDis give minimize risk gout flare washout/run-in period double study period .</detailed_description>
	<mesh_term>Gout</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Febuxostat</mesh_term>
	<criteria>&lt; Day 14 &gt; 1. age :1885 year 2. female : either postmenopausal least 2 year , surgically sterile , use medically accept mean contraception 3. female : negative serum pregnancy test 4. subject satisfy ARA ( American Rheumatism Association ) 5. subject must renal function define : serum creatinine ≤ 1.5 mg/dL &lt; Day 1 &gt; 1.serum urate level ≥8.0mg/dL 2.creatinine level ≤ 1.5mg/dL 3.subject continued meet inclusion exclusion criterion 1. woman breastfeed pregnant 2. history xanthinuria 3. allopurinol intolerance 4. receive thiazide diuretic therapy 5. secondary hyperuricemia 6. require &gt; 10mg/day prednisone study stable dose ( ≤10mg/day ) , inhale intranasal steroid allow . 7. concomitant therapy contain aspirin salicylate ( systemic topical , prescribe nonprescribed ) stable , low dos aspirin allow ( i.e . ≤325mg/day ) . 8. change hormone replacement therapy oral contraceptive therapy within 3 month screen visit 9. alcohol intake≥ 14drinks/week alcohol abuse within 5 year current excessive alcohol use prohibit . 10. concomitant therapy uratelowering therapy 11. active liver disease hepatic dysfunction : ALT , AST ≥1.5 ULN 12. subject unable take colchicine contradictory colchicine 13. serum urate level &lt; 8.0mg/dL take uric acid lower therapy 14. rheumatoid arthritis active arthritis require medication treatment 15. history cancer ( basal cell carcinoma skin ) within 5 year prior screen visit , take systemic cancer chemotherapy within 5 year prior screen visit 16. participate another investigational trial within 30days prior screen visit 17. significant medical condition define investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>